Idiopathic achalasia
Other Names: Esophageal achalasia; Primary achalasia; Achalasia cardia; Idiopathic achalasia of esophagus; Achalasia
Achalasia is a disorder of the esophagus, the tube that carries food from the mouth to the stomach. It is characterized by enlargement of the esophagus, impaired ability of the esophagus to push food down toward the stomach (peristalsis), and failure of the ring-shaped muscle at the bottom of the esophagus (the lower esophageal sphincter) to relax.
Achalasia is typically diagnosed in individuals between 25 and 60 years of age.
Familial studies have shown evidence of a potential genetic influence. When a genetic influence is suspected, achalasia is called familial esophageal achalasia.

Cause[edit]
The lower esophageal sphincter, the ring-shaped muscle at the bottom of the esophagus, normally relaxes during swallowing. In people with achalasia, this muscle ring does not relax as well. The reason for this problem is damage to the nerves of the esophagus. In some people, this problem appears to be inherited. There is additionally a suspected autoimmune component involved in the development of achalasia as individuals with achalasia are more likely to have a concomitant autoimmune disease than the general population.
Inheritance[edit]
Some familial cases have been reported, but the rarity of familial occurrence does not support the hypothesis that genetic inheritance is a significant etiologic factor.
Signs and symptoms[edit]
Most people with achalasia experience difficulty swallowing, also known as dysphagia and heartburn. Other symptoms might include: regurgitation or vomiting, noncardiac chest pain, odynophagia (painful swallowing), and pain in the upper central region of the abdomen. Non esophageal symptoms might include: coughing or asthma, chronic aspiration (breathing a foreign object such as food into the airway), hoarseness or sore throat, and unintentional weight loss.
For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed. 80%-99% of people have these symptoms
- Dysphagia(Poor swallowing)
30%-79% of people have these symptoms
- Bronchitis
- Chest pain
- Cough(Coughing)
- Gastroesophageal reflux(Acid reflux)
- Weight loss
5%-29% of people have these symptoms
- Decreased prealbumin level
- Malnutrition
- Recurrent aspiration pneumonia
- Wheezing
Diagnosis[edit]
Achalasia is suspected in individuals with dysphagia (difficulty swallowing) and in instances where regurgitation symptoms are not responsive to protein pump inhibitor medication.
The diagnosis of achalasia is confirmed by manometry (test that measures how well the esophagus is working); however, other tests such as upper endoscopy and upper GI X-ray can additionally be useful.
Treatment[edit]
The aim of treatment is to reduce the pressure at the lower esophageal sphincter. Therapy may involve:
- Injection with botulinum toxin (Botox) to help relax the sphincter muscles (used as a temporary fix)
- Medications, such as long-acting nitrates (i.e. isosorbide dinitrate) or calcium channel blockers (i.e. nifedipine), to relax the lower esophagus sphincter
- Surgery (Heller myotomy) to decrease the pressure in the lower sphincter
- Pneumatic balloon dilation of the esophagus at the location of the narrowing (done during esophagogastroduodenoscopy)
Prognosis[edit]
Although there is no cure for achalasia, treatment options are estimated to be effective in 90% of cases. Without treatment, individuals with achalasia develop progressive dilation of the esophagus. This then leads to late or end-stage achalasia, characterized by esophageal tortuosity (twisting and turning), angulation, and severe dilation.
Approximately 10-15% of individuals who have undergone treatment will progress to late or end-stage achalasia. Treatment for late or end-stage achalasia is typically esophagectomy (surgery to remove all or part of the esophagus).
- U.S. Society for Surgery of the Alimentary Tract - Achalasia treatment guidelines
NIH genetic and rare disease info[edit]
Idiopathic achalasia is a rare disease.
| Rare and genetic diseases | ||||||
|---|---|---|---|---|---|---|
|
Rare diseases - Idiopathic achalasia
|
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


